Cargando…

Disclosure of cancer diagnosis and quality of life in cancer patients: should it be the same everywhere?

BACKGROUND: Evidence suggests that truth telling and honest disclosure of cancer diagnosis could lead to improved outcomes in cancer patients. To examine such findings in Iran, this trial aimed to study the various dimensions of quality of life in patients with gastrointestinal cancer and to compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Montazeri, Ali, Tavoli, Azadeh, Mohagheghi, Mohammad Ali, Roshan, Rasool, Tavoli, Zahra
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2639611/
https://www.ncbi.nlm.nih.gov/pubmed/19178719
http://dx.doi.org/10.1186/1471-2407-9-39
_version_ 1782164484709679104
author Montazeri, Ali
Tavoli, Azadeh
Mohagheghi, Mohammad Ali
Roshan, Rasool
Tavoli, Zahra
author_facet Montazeri, Ali
Tavoli, Azadeh
Mohagheghi, Mohammad Ali
Roshan, Rasool
Tavoli, Zahra
author_sort Montazeri, Ali
collection PubMed
description BACKGROUND: Evidence suggests that truth telling and honest disclosure of cancer diagnosis could lead to improved outcomes in cancer patients. To examine such findings in Iran, this trial aimed to study the various dimensions of quality of life in patients with gastrointestinal cancer and to compare these variables among those who knew their diagnosis and those who did not. METHODS: A consecutive sample of patients with gastrointestinal cancer being treated in Cancer Institute in Tehran, Iran was prospectively evaluated. A psychologist interviewed patients using the Iranian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). Patients were categorized into two groups: those who knew their diagnosis and those who did not. Independent sample t-test was used for group comparisons. RESULTS: In all 142 patients were interviewed. A significant proportion (52%) of patients did not know their cancer diagnosis and 48% of patients were aware that they had cancer. They were quite similar in most characteristics. The comparison of quality of life between two groups indicated that those knew their diagnosis showed a significant lower degree of physical (P = 0.001), emotional (P = 0.01) and social functioning (P < 0.001), whereas the global quality of life and other functional scales including role functioning and cognitive functioning did not show significant result. There were no statistically significant differences between symptoms scores between two groups, except for fatigue suggesting a higher score in patients who knew their diagnosis (P = 0.01). The financial difficulties were also significantly higher in patients who knew their cancer diagnosis (P = 0.005). Performing analysis of variance while controlling for age, educational status, cancer site, and knowledge of cancer diagnosis, the results showed that the knowledge of cancer diagnosis independently still contributed to the significant differences observed between two groups. CONCLUSION: Contrary to expectation the findings indicated that patients who did not know their cancer diagnosis had a better physical, social and emotional quality of life. It seems that due to cultural differences between countries cancer disclosure guidelines perhaps should be differing.
format Text
id pubmed-2639611
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26396112009-02-11 Disclosure of cancer diagnosis and quality of life in cancer patients: should it be the same everywhere? Montazeri, Ali Tavoli, Azadeh Mohagheghi, Mohammad Ali Roshan, Rasool Tavoli, Zahra BMC Cancer Research Article BACKGROUND: Evidence suggests that truth telling and honest disclosure of cancer diagnosis could lead to improved outcomes in cancer patients. To examine such findings in Iran, this trial aimed to study the various dimensions of quality of life in patients with gastrointestinal cancer and to compare these variables among those who knew their diagnosis and those who did not. METHODS: A consecutive sample of patients with gastrointestinal cancer being treated in Cancer Institute in Tehran, Iran was prospectively evaluated. A psychologist interviewed patients using the Iranian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). Patients were categorized into two groups: those who knew their diagnosis and those who did not. Independent sample t-test was used for group comparisons. RESULTS: In all 142 patients were interviewed. A significant proportion (52%) of patients did not know their cancer diagnosis and 48% of patients were aware that they had cancer. They were quite similar in most characteristics. The comparison of quality of life between two groups indicated that those knew their diagnosis showed a significant lower degree of physical (P = 0.001), emotional (P = 0.01) and social functioning (P < 0.001), whereas the global quality of life and other functional scales including role functioning and cognitive functioning did not show significant result. There were no statistically significant differences between symptoms scores between two groups, except for fatigue suggesting a higher score in patients who knew their diagnosis (P = 0.01). The financial difficulties were also significantly higher in patients who knew their cancer diagnosis (P = 0.005). Performing analysis of variance while controlling for age, educational status, cancer site, and knowledge of cancer diagnosis, the results showed that the knowledge of cancer diagnosis independently still contributed to the significant differences observed between two groups. CONCLUSION: Contrary to expectation the findings indicated that patients who did not know their cancer diagnosis had a better physical, social and emotional quality of life. It seems that due to cultural differences between countries cancer disclosure guidelines perhaps should be differing. BioMed Central 2009-01-29 /pmc/articles/PMC2639611/ /pubmed/19178719 http://dx.doi.org/10.1186/1471-2407-9-39 Text en Copyright ©2009 Montazeri et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Montazeri, Ali
Tavoli, Azadeh
Mohagheghi, Mohammad Ali
Roshan, Rasool
Tavoli, Zahra
Disclosure of cancer diagnosis and quality of life in cancer patients: should it be the same everywhere?
title Disclosure of cancer diagnosis and quality of life in cancer patients: should it be the same everywhere?
title_full Disclosure of cancer diagnosis and quality of life in cancer patients: should it be the same everywhere?
title_fullStr Disclosure of cancer diagnosis and quality of life in cancer patients: should it be the same everywhere?
title_full_unstemmed Disclosure of cancer diagnosis and quality of life in cancer patients: should it be the same everywhere?
title_short Disclosure of cancer diagnosis and quality of life in cancer patients: should it be the same everywhere?
title_sort disclosure of cancer diagnosis and quality of life in cancer patients: should it be the same everywhere?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2639611/
https://www.ncbi.nlm.nih.gov/pubmed/19178719
http://dx.doi.org/10.1186/1471-2407-9-39
work_keys_str_mv AT montazeriali disclosureofcancerdiagnosisandqualityoflifeincancerpatientsshoulditbethesameeverywhere
AT tavoliazadeh disclosureofcancerdiagnosisandqualityoflifeincancerpatientsshoulditbethesameeverywhere
AT mohagheghimohammadali disclosureofcancerdiagnosisandqualityoflifeincancerpatientsshoulditbethesameeverywhere
AT roshanrasool disclosureofcancerdiagnosisandqualityoflifeincancerpatientsshoulditbethesameeverywhere
AT tavolizahra disclosureofcancerdiagnosisandqualityoflifeincancerpatientsshoulditbethesameeverywhere